Drug Database
Back to search

Poland· PL-100379249

Starazolin Alergia

A olopatadine product containing olopatadinum, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A.. The same ATC class is registered in 13 of our 19 countries.

ATC S01GX09

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedStarazolin AlergiaATCS01GX09REGISTER NO.PL-100379249PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about olopatadinumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Olopatadine is registered in 13 of 19 countries.

Countries holding a registration under ATC S01GX09 (olopatadine), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose
Search olopatadine products by name

Olopatadine · ATC S01GX09

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Olopatadinum
Manufacturer
Zakłady Farmaceutyczne POLPHARMA S.A.
Country
Poland (PL)
ATC code
S01GX09
ATC class
Olopatadine
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991402563
  • gtin
    05900257102227
  • gtin
    05900257102494

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

142 interactions on record for olopatadine.

Graded by severity as the source publishes them — 142 info. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check olopatadine against other medicinesHow interaction checks work

Olopatadine · interactions on record

142 records

  • 142 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Olopatadine in 15 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All olopatadine products

    Authorised across Europe · EMA

    The same active substance is authorised in 26 EEA countries. Names it is sold under:

    • Austria · Olopatadin Micro Labs, Olopatadin Unimed Pharma
    • Bulgaria · Оловижън, Олопатадин Унимед Фарма
    • Cyprus · Alopatan, Olopatadine Rafarm
    • Czechia · Olopatadine Unimed Pharma, Olopatidine Olikla
    • Germany · Alltrevo, Olopatadin Actrevo
    • Denmark · Olopatadin Brown & Burk, Olopatadin Juta
    • Estonia · Olopatadine Unimed Pharma
    • Spain · Apadin, Olopatadina Abamed
    • United Kingdom (Northern Ireland) · Olopatadine Blumont Pharma, Olopatadine Brown & Burk Uk
    • Greece · Alopatan, Olopatadine Rafarm
    • Croatia · Olopatadin
    • Hungary · Olopatadine Unimed Pharma
    • Ireland · Olopatadine Brown & Burk
    • Iceland · Opatanol
    • Italy · Calmira®, Olonet
    • Liechtenstein · Opatanol
    • Lithuania · Olopatadine Unimed Pharma
    • Latvia · Olopatadine Unimed Pharma
    • Malta · Olopatadine Unimed Pharma
    • Netherlands · Olopatadine Brown & Burk, Optamont
    • Norway · Olopatadine Sandoz, Opatanol
    • Portugal · Olopatadina Stallpharma
    • Romania · Olopatadina Brown & Burk, Olopatadină Rompharm
    • Sweden · Olopatadin Evolan, Olopatadin Orifarm
    • Slovenia · Olopatadin Unimed Pharma
    • Slovakia · Olopatadine Olikla, Olopatadine Unimed Pharma

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/0c3250d9-3f39-4ba8-aa10-74de1b46e332
GET /v1/drugs/0c3250d9-3f39-4ba8-aa10-74de1b46e332?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Krople do oczu, roztwór",
  "source": "urpl",
  "strength": "1 mg/ml",
  "packaging": "05909991402563 ¦ OTC ¦ Skasowane ¦ 132157\n1 butelka 5 ml\n05900257102227 ¦ OTC ¦ 138012\n1 butelka  po 5 ml\n05900257102494 ¦ OTC ¦ 145581\n2 butelki  po 5 ml",
  "substance": "Olopatadinum 1 mg/ml",
  "common_name": "Olopatadinum",
  "pl_product_id": "100379249",
  "pozwolenie_nr": "25314",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about olopatadine.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console